Skip to content

AQI and Childhood Asthma: an Intervention

Air Quality Index (AQI) and Childhood Asthma: an Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04454125
Enrollment
40
Registered
2020-07-01
Start date
2020-07-14
Completion date
2021-03-22
Last updated
2023-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Asthma in Children

Keywords

Air Quality Index (AQI), Childhood asthma exacerbations

Brief summary

This is a small pilot prospective intervention trial in children with asthma who will be randomized to receive either (A) Air Quality Index (AQI) education + an asthma action plan (control) or (B) AQI education + an asthma action plan which contains AQI behavioral recommendations + demonstrate ability to navigate to AirNow either online or on smartphone app (intervention).

Detailed description

Over 3 million US children with asthma reported at least one attack in the prior year. Poorly controlled asthma is a major cause of suffering, school absences, loss of caregiver productivity, and healthcare costs (estimated as \ $80 billion/year). Over half of children on controller medication are not well controlled, due to environmental exposures, non-adherence, or true non-response to treatment. Outdoor air pollution is a known trigger of asthma. Although sound health policies are the best long-term approaches to reduce the harmful effects of air pollution, exposure avoidance is needed until clean air is ensured through effective legislation. Despite this, healthcare providers infrequently provide pollution exposure advice to children with asthma. The Environmental Protection Agency (EPA) monitors air pollution and reports a daily Air Quality Index (AQI) that is easy to use and available in most metropolitan areas. Practical recommendations regarding outdoor activity can be based on AQI levels. Despite this, AQI-based recommendations are rarely addressed in asthma action plans (AAP). No pediatric study has assessed the addition of the AQI to AAP to reduce asthma morbidity. This proposal seeks to recruit a pilot cohort of 40 children with asthma. Using this cohort, the investigators will test the hypotheses that (1) the addition of the AQI to AAP will reduce asthma exacerbations and (2) the addition of the AQI to AAP will improve asthma symptom control & quality of life in children with asthma. The inclusion of the AQI onto asthma action plans is novel in clinical asthma care; its wide availability would make large-scale implementation feasible. The investigators expect this low-cost and low-tech intervention will have a positive impact in reducing asthma morbidity. Given that 1 out of every 12 children in the U.S. has asthma, this is relevant to health care professionals, parents, and public health practitioners. Optional, the investigators will collect nasal epithelial cells for use in future genomic/epigenetic studies. Additionally, 40 parents/guardians of the children were also recruited to complete a baseline parental knowledge and usage of the AQI questionnaire administered at the randomization visit. This was originally listed as a secondary outcome however was removed during reporting of results as parental knowledge is not a true clinical trial outcome. Also, the secondary outcome of baseline child AQI usage (checking AQI) was changed to reflect this was a measure collected at all study visits and the secondary measure of physical activity was added.

Interventions

BEHAVIORALAQI intervention

The intervention arm will receive AQI education, an asthma action plan containing AQI information and recommendations, and will be required to demonstrate ability to check AQI (either via airnow.gov website or downloaded AirNow smartphone app).

OTHERRoutine care

The routine care arm will be provided with general AQI education and an asthma action plan not containing AQI information.

Sponsors

American Thoracic Society
CollaboratorOTHER
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Unblinded

Intervention model description

40 child will be 1:1 randomization by age groups 8-12 years, 13-17 years.

Eligibility

Sex/Gender
ALL
Age
8 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Child Inclusion criteria includes: 1. physician diagnosis of persistent asthma- either mild, moderate, or severe; 2. family home internet access and/or smartphone access + willingness to download AirNow app on phone; 3. age 8-17 years. Parent/guardian inclusion: parent or guardian of the child participant, of whom has met inclusion criteria.

Exclusion criteria

* Child

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With at Least One Moderate or Severe Asthma Exacerbation Over TimeOver study duration (up to 6 months)Moderate and severe asthma exacerbations were captured via questionnaire administered monthly for up to 6 months. Severe and moderate exacerbations were defined by American Thoracic Society (ATS) criteria.
Mean Change in Asthma Control Over TimeOver study duration (up to 6 months)Asthma symptom control was measured by the validated Asthma Control Test (ACT) or Childhood Asthma Control Test (CACT) questionnaires as age appropriate (ACT in children 12 year of age or older; CACT for children younger than 12 years of age). ACT and CACT were obtained at baseline and every 4 weeks for up to 6 months. Differences in asthma control scores were compared both within arms and between arms at study end. ACT (min=5, max=25, score of \<=19 concerning for poor asthma control; \<=15 concerning for very poorly controlled). CACT (min=0, max=27, score of \<=19 concerning for poor asthma control; \<=12 concerning for very poorly controlled)
Mean Change in Pediatric Asthma Quality of Life Over TimeBaseline, 6 monthsQuality of life will be measured by the validated Pediatric Asthma Quality of Life Questionnaire with standardized activities (PAQLQ) at entrance and exit visits. Differences in PAQLQ scores will be compared both within arms and between arms at study end. PAQLQ (min=1 (extremely bothered/all the time), max=7 (not bothered/none of the time)

Secondary

MeasureTime frameDescription
Number of Participants Who Reported Checking the AQI Prior to Going Outside to be ActiveOver study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.Participant reported checking of AQI prior to going outside to be active assessed via questionnaire. Question: In the past 4 weeks, did you check the air quality index before going outside to be active? Response choices: Yes, No.
Number of Participated Who Reported Outdoor Activity Behavioral Change in Response to the AQIOver study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.Usage of the AQI prior to exercise was monitored monthly via questionnaire. Question: In the past 4 weeks, how many times did you change your outdoor activity because of the air quality index? Response choices: All of the time, Most of the time, Some of the time, A little of the time, None of the time. A positive response was considered an answer of all, most, some, or a little of the time. A negative response was considered none of the time.
Number of Participants Who Reported Moderate or Vigorous Physical Activity for at Least 10 Minutes Continuously Outside in a Typical WeekOver study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.Outcome obtained from physical activity questionnaire. Yes represents a positive response to at least one of the follow two questions: Question 1: In a typical week {do you/does SP} do any vigorous-intensity sports, fitness, or recreational activities that cause large increases in breathing or heart rate like running or basketball for at least 10 minutes continuously outside? Response choices: Yes, No, Refused, Don't Know. Note: refused and don't know were coded as negative. Question 2: In a typical week, {do you/does SP} do any moderate-intensity sports, fitness, or recreational activities that cause a small increase in breathing or heart rate such as brisk walking, bicycling, swimming, or volleyball for at least 10 minutes continuously outside? Response choices: Yes, No, Refused, Don't Know. Note: refused and don't know were coded as negative.

Countries

United States

Participant flow

Participants by arm

ArmCount
Routine Care
Routine care: The routine care arm will be provided with general AQI education and an asthma action plan not containing AQI information.
20
AQI Intervention
AQI intervention: The intervention arm will receive AQI education, an asthma action plan containing AQI information and recommendations, and will be required to demonstrate ability to check AQI (either via airnow.gov website or downloaded AirNow smartphone app).
20
Total40

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up01

Baseline characteristics

CharacteristicTotalAQI InterventionRoutine Care
Age, Categorical
<=18 years
40 Participants20 Participants20 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous12.5 years
STANDARD_DEVIATION 2.7
12.5 years
STANDARD_DEVIATION 2.9
12.5 years
STANDARD_DEVIATION 2.6
Asthma Control Test (ACT)21.0 score on a scale
STANDARD_DEVIATION 3.8
21.2 score on a scale
STANDARD_DEVIATION 3
20.9 score on a scale
STANDARD_DEVIATION 4.6
At least one severe asthma exacerbation in the past 12 months, yes24 Participants13 Participants11 Participants
Body Mass Index z-score (BMIz)1.27 z score
STANDARD_DEVIATION 1.29
1.03 z score
STANDARD_DEVIATION 1.22
1.51 z score
STANDARD_DEVIATION 1.35
Childhood Asthma Control Test (CACT)21.6 score on a scale
STANDARD_DEVIATION 5.8
20.7 score on a scale
STANDARD_DEVIATION 8.3
22.6 score on a scale
STANDARD_DEVIATION 1.3
Pediatric Asthma Quality of Life Questionnaire6.03 score on a scale
STANDARD_DEVIATION 0.93
6.11 score on a scale
STANDARD_DEVIATION 0.84
5.96 score on a scale
STANDARD_DEVIATION 1.02
Race/Ethnicity, Customized
Black
15 Participants6 Participants9 Participants
Race/Ethnicity, Customized
More than 1 race
7 Participants4 Participants3 Participants
Race/Ethnicity, Customized
White
18 Participants10 Participants8 Participants
Region of Enrollment
United States
40 Participants20 Participants20 Participants
Reported any change in outdoor activity because of the AQI, yes8 Participants3 Participants5 Participants
Reported checking the AQI prior to going outside to be active, yes4 Participants2 Participants2 Participants
Reported moderate or vigorous activity for at least 10 minutes outside in a typical week, yes32 Participants18 Participants14 Participants
Sex: Female, Male
Female
20 Participants10 Participants10 Participants
Sex: Female, Male
Male
20 Participants10 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
3 / 204 / 20
serious
Total, serious adverse events
2 / 201 / 20

Outcome results

Primary

Mean Change in Asthma Control Over Time

Asthma symptom control was measured by the validated Asthma Control Test (ACT) or Childhood Asthma Control Test (CACT) questionnaires as age appropriate (ACT in children 12 year of age or older; CACT for children younger than 12 years of age). ACT and CACT were obtained at baseline and every 4 weeks for up to 6 months. Differences in asthma control scores were compared both within arms and between arms at study end. ACT (min=5, max=25, score of \<=19 concerning for poor asthma control; \<=15 concerning for very poorly controlled). CACT (min=0, max=27, score of \<=19 concerning for poor asthma control; \<=12 concerning for very poorly controlled)

Time frame: Over study duration (up to 6 months)

Population: The mean change was obtained, via generalized linear modeling (glm), taking into account the correlation of repeat measures. The values are listed by group and contain all available time points averaged.

ArmMeasureGroupValue (MEAN)
Routine CareMean Change in Asthma Control Over TimeAsthma Control Test0.17 score on a scale
Routine CareMean Change in Asthma Control Over TimeChildhood Asthma Control Test-0.31 score on a scale
AQI InterventionMean Change in Asthma Control Over TimeAsthma Control Test2.02 score on a scale
AQI InterventionMean Change in Asthma Control Over TimeChildhood Asthma Control Test3.96 score on a scale
Comparison: Outcome=Childhood Asthma Control Test Score. Obtained at all visits.p-value: 0.1495% CI: [-1.27, 9.2]generalized linear model, repeat measure
Comparison: Outcome=Childhood Asthma Control Test Scores.p-value: 0.1395% CI: [-1.19, 9.73]generalized linear model, repeat measure
Comparison: Outcome=Asthma Control Test Score. Obtained at all visits.p-value: 0.895% CI: [-1.17, 1.51]generalized linear model, repeat measure
Comparison: Outcome=Asthma Control Test Score. Obtained at all visits.p-value: 0.00195% CI: [0.88, 3.15]generalized linear model, repeat measure
Comparison: Outcome=Asthma Control Test Score. Obtained at all visits.p-value: 0.0495% CI: [0.09, 3.61]generalized linear model, repeat measure
Comparison: Outcome=Childhood Asthma Control Test Score. Obtained at all visits.p-value: 0.795% CI: [-1.87, 1.25]generalized linear model, repeat measure
Primary

Mean Change in Pediatric Asthma Quality of Life Over Time

Quality of life will be measured by the validated Pediatric Asthma Quality of Life Questionnaire with standardized activities (PAQLQ) at entrance and exit visits. Differences in PAQLQ scores will be compared both within arms and between arms at study end. PAQLQ (min=1 (extremely bothered/all the time), max=7 (not bothered/none of the time)

Time frame: Baseline, 6 months

Population: 1 participant lost to follow up at exit visit

ArmMeasureValue (MEAN)
Routine CareMean Change in Pediatric Asthma Quality of Life Over Time0.25 score on a scale
AQI InterventionMean Change in Pediatric Asthma Quality of Life Over Time0.54 score on a scale
Comparison: Outcome: Pediatric Asthma Quality of Life Questionnaire. Obtained at randomization and exit visits (visit 1 and visit 7).p-value: 0.1195% CI: [-0.06, 0.55]generalized linear model, repeat measure
Comparison: Outcome: Pediatric Asthma Quality of Life Questionnaire. Obtained at randomization and exit visits (visit 1 and visit 7).p-value: 0.00295% CI: [0.2, 0.88]generalized linear model, repeat measure
Comparison: Outcome: Pediatric Asthma Quality of Life Questionnaire. Obtained at randomization and exit visits (visit 1 and visit 7).p-value: 0.295% CI: [-0.16, 0.75]generalized linear model, repeat measure
Primary

Number of Participants With at Least One Moderate or Severe Asthma Exacerbation Over Time

Moderate and severe asthma exacerbations were captured via questionnaire administered monthly for up to 6 months. Severe and moderate exacerbations were defined by American Thoracic Society (ATS) criteria.

Time frame: Over study duration (up to 6 months)

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Routine CareNumber of Participants With at Least One Moderate or Severe Asthma Exacerbation Over TimeAt least one severe asthma exacerbation during study, yes5 Participants
Routine CareNumber of Participants With at Least One Moderate or Severe Asthma Exacerbation Over TimeAt least one moderate asthma exacerbation during study, yes13 Participants
AQI InterventionNumber of Participants With at Least One Moderate or Severe Asthma Exacerbation Over TimeAt least one severe asthma exacerbation during study, yes4 Participants
AQI InterventionNumber of Participants With at Least One Moderate or Severe Asthma Exacerbation Over TimeAt least one moderate asthma exacerbation during study, yes12 Participants
Comparison: Outcome= severe asthma exacerbation at visit (yes, no), collected via questionnaire at visits 2-7(exit). Does not include randomization (visit 1).p-value: 0.3295% CI: [0.23, 1.61]Generalized linear model, repeat measure
Comparison: Outcome= severe asthma exacerbation at visit (yes, no), collected via questionnaire at visits 2-7(exit). Does not include randomization (visit 1).p-value: 0.2995% CI: [0.03, 2.76]generalized linear model, repeat measure
Comparison: Outcome= severe asthma exacerbation at visit (yes, no), collected via questionnaire at visits 2-7(exit). Does not include randomization (visit 1).p-value: 0.5895% CI: [0.05, 5.68]generalized linear model, repeat measure
Comparison: Outcome= moderate asthma exacerbation at visit (yes, no), collected via questionnaire at visits 2-7(exit). Does not include randomization (visit 1).p-value: 0.0295% CI: [0.27, 0.91]generalized linear model, repeat measure
Comparison: Outcome= moderate asthma exacerbation at visit (yes, no), collected via questionnaire at visits 2-7(exit). Does not include randomization (visit 1).p-value: 0.0395% CI: [0.06, 0.86]generalized linear model, repeat measure
Comparison: Outcome= moderate asthma exacerbation at visit (yes, no), collected via questionnaire at visits 2-7(exit). Does not include randomization (visit 1).p-value: 0.395% CI: [0.11, 1.95]generalized linear model, repeat measure
Secondary

Number of Participants Who Reported Checking the AQI Prior to Going Outside to be Active

Participant reported checking of AQI prior to going outside to be active assessed via questionnaire. Question: In the past 4 weeks, did you check the air quality index before going outside to be active? Response choices: Yes, No.

Time frame: Over study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.

Population: 1 participant lost to follow up at exit visit; all participant data (n=40) was included in glm analyses as presented in statistical analyses.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Routine CareNumber of Participants Who Reported Checking the AQI Prior to Going Outside to be Active3 Participants
AQI InterventionNumber of Participants Who Reported Checking the AQI Prior to Going Outside to be Active12 Participants
Comparison: Outcome: Reported checking the AQI prior to going outside to be activep-value: 0.8795% CI: [0.45, 1.96]generalized linear model, repeat measure
Comparison: Outcome: Reported checking the AQI prior to going outside to be activep-value: 0.00495% CI: [1.85, 25.6]generalized linear model, repeat measure
Comparison: Outcome: Reported checking the AQI prior to going outside to be activep-value: 0.0195% CI: [1.62, 32.9]generalized linear model, repeat measure
Secondary

Number of Participants Who Reported Moderate or Vigorous Physical Activity for at Least 10 Minutes Continuously Outside in a Typical Week

Outcome obtained from physical activity questionnaire. Yes represents a positive response to at least one of the follow two questions: Question 1: In a typical week {do you/does SP} do any vigorous-intensity sports, fitness, or recreational activities that cause large increases in breathing or heart rate like running or basketball for at least 10 minutes continuously outside? Response choices: Yes, No, Refused, Don't Know. Note: refused and don't know were coded as negative. Question 2: In a typical week, {do you/does SP} do any moderate-intensity sports, fitness, or recreational activities that cause a small increase in breathing or heart rate such as brisk walking, bicycling, swimming, or volleyball for at least 10 minutes continuously outside? Response choices: Yes, No, Refused, Don't Know. Note: refused and don't know were coded as negative.

Time frame: Over study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.

Population: 1 participant lost to follow up at exit visit; all participant data (n=40) was included in glm analyses as presented in statistical analyses.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Routine CareNumber of Participants Who Reported Moderate or Vigorous Physical Activity for at Least 10 Minutes Continuously Outside in a Typical Week9 Participants
AQI InterventionNumber of Participants Who Reported Moderate or Vigorous Physical Activity for at Least 10 Minutes Continuously Outside in a Typical Week7 Participants
Comparison: Obtained at all visitsp-value: 0.00495% CI: [0.24, 0.76]generalized linear model, repeat measure
Comparison: Obtained at all visits.p-value: <0.000195% CI: [0.05, 0.31]generalized linear model, repeat measure
Comparison: Obtained at all visits.p-value: 0.0395% CI: [0.1, 0.87]generalized linear model, repeat measure
Secondary

Number of Participated Who Reported Outdoor Activity Behavioral Change in Response to the AQI

Usage of the AQI prior to exercise was monitored monthly via questionnaire. Question: In the past 4 weeks, how many times did you change your outdoor activity because of the air quality index? Response choices: All of the time, Most of the time, Some of the time, A little of the time, None of the time. A positive response was considered an answer of all, most, some, or a little of the time. A negative response was considered none of the time.

Time frame: Over study duration, assessed at baseline and monthly during study for up to 6 months. Reported below at exit.

Population: 1 participant lost to follow up at exit visit; all participant data (n=40) was included in glm analyses as presented in statistical analyses.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Routine CareNumber of Participated Who Reported Outdoor Activity Behavioral Change in Response to the AQI2 Participants
AQI InterventionNumber of Participated Who Reported Outdoor Activity Behavioral Change in Response to the AQI7 Participants
Comparison: Outcome: Reported outdoor activity behavioral change in response to the AQI, obtained at all visits.p-value: 0.1595% CI: [0.08, 1.47]generalized linear model, repeat measure
Comparison: Outcome: Reported outdoor activity behavioral change in response to the AQI, obtained at all visits.p-value: 0.9495% CI: [0.35, 2.68]generalized linear model, repeat measure
Comparison: Outcome: Reported outdoor activity behavioral change in response to the AQI, obtained at all visits.p-value: 0.2695% CI: [0.47, 16.5]generalized linear model, repeat measure

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026